Ried et al “Comparative Genomic Hybridization Reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors” Genes, Chromosomes, and Cancer, vol. 15, p. 235-245, 1996.* |
Collins et al “Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma” Proc. Natl. Acad. vol. 95, p. 8703-8708, Jul. 1998.* |
Wang et at “Cot-1 Banding of Human choromosomes using FISH hybridization with CY3 labeling” Jpn. J. Hum. Genetics, vol. 40, p. 243-252, 1995.* |
Korn et al “Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastic to liver, as analyzed by CGH and FISH” Genes, Chromosomes, and Cancer, vol. 25, p. 82-90, Jun. 1999.* |
Brown et al “Exploring the new world of the genome with DNA microarrays” Nature Genetics Supplement, vol. 21, p. 33-37, Jan. 1999.* |
Schlegel et al “Comparative Genomic in Situ hybridization of Colon carcinomas with Replication error” Cancer Research, vol. 55, p. 6002-6005, Dec. 1995.* |
Nanashima et al “Gain of Chromosome 20 is a frequent aberration in liver metastasis of colorectal cancers” Digestive Disease and Sciences, vol. 42, No. 7, p. 1388-1393, Jul. 1997.* |
Korn et al “Characterization of copy number increases of chromosome 20q sequences in hepatic of colorectal cancer by FISH” Proc. of the Am. Association for Cancer Research, vol. 39, p. 346, Mar. 1998.* |
Bischoff et al “A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers” The EMBO Journal, vol. 17, No. 11, p. 3052-3065, Jun. 17, 1998.* |
Savelieva et al “20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells” Oncogene, vol. 14, No. 5, p. 551-560, Feb. 1997.* |
Nakao et al “Genetic Changes in Primary colorectal cancer by CGH” Jpn. J. Surg. vol. 28, No. 5, p. 567-569, 1998.* |
Meijer et al “Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by CGH” J. Clinical Pathology, vol. 51, p. 901-909, Dec. 1998.* |
Baker et al., “p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis,” Cancer Research (1990) 50: 7717-22. |
Fearon and Vogelstein, “A genetic model for colorectal tumorigenesis,” Cell (1990) 61: 759-767. |
Vogelstein et al., “Genetic alterations during colorectal-tumor development,” New England Journal of Medicine (1988) 319: 525. |